Intuitive Surgical, Inc.

ISRG ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $2.86B $2.32B $1.80B $1.32B $1.70B $1.06B $1.38B $1.13B
Depreciation & Amortization — — — — — — — —
Depreciation $600.0M $439.0M $382.0M $326.0M $280.0M $221.0M $157.0M $105.9M
Amortization $13.2M $16.7M $20.2M $27.8M $27.4M $49.8M $43.0M $14.2M
Stock-Based Compensation $788.2M $676.8M $592.8M $513.2M $449.2M $395.4M $335.8M $261.2M
Net Cash from Operating Activities $3.03B $2.42B $1.81B $1.49B $2.09B $1.48B $1.60B $1.17B
Investing Activities
Capital Expenditures $539.8M $1.11B $1.06B $532.4M $339.5M $341.5M $425.6M $187.4M
Business Acquisitions $13.9M $1.0M $8.9M $12.8M $22.7M $37.7M $59.7M $87.9M
Net Cash from Investing Activities $665.8M $-3.27B $-360.1M $1.37B $-2.46B $-940.6M $-1.15B $-1.05B
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $2.30B $0 $416.3M $2.61B $0 $134.3M $269.5M $0
Net Cash from Financing Activities $-2.36B $150.9M $-287.6M $-2.57B $43.0M $-85.7M $-168.4M $126.3M
Net Change in Cash $1.35B $-707.7M $1.17B $294.7M $-332.5M $455.9M $273.2M $246.2M
Free Cash Flow $2.49B $1.30B $749.6M $958.4M $1.75B $1.14B $1.17B $982.2M
← Newer Page 1 of 3 Older →